Loading provider…
Loading provider…
Dermatology Physician in Lynchburg, VA
NPI: 1194748012HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 12032Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 204 | 211 |
| 2 | 11602Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 124 | 134 |
| 3 | 12042Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals | 39 | 39 |
| 4 | 11402Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 38 | 41 |
| 5 | 17262Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 37 | 44 |
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Authors: Janet Dubois, John Tu, Kavita Sarin, Scott Plotkin, Sunil Dhawan
Journal: Sci Adv
Publication Date: 2024-05-01
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).
Authors: Stuart Shanler, Joel Schlessinger, Andrew Blauvelt
Publication Date: 2018-04-05
Lead Sponsor: NFlection Therapeutics, Inc.
Intervention / Treatment: DRUG: Vehicle Gel, DRUG: NFX-179 Gel
Lead Sponsor: Sol-Gel Technologies, Ltd.
Intervention / Treatment: DRUG: S2G6T-1, DRUG: S2G6T-2, DRUG: S2G6T-3, DRUG: S2G6T-4
Lead Sponsor: G&E Herbal Biotechnology Co., LTD
Intervention / Treatment: DRUG: Vehicle gel, DRUG: SR-T100 with 2.3% of SM